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Abstract
Myocardial function is depressed in sepsis and is an important prognosticator in the human condition. Using
echocardiography in a long-term fluid-resuscitated Wistar rat model of faecal peritonitis we investigated whether
depressed myocardial function could be detected at an early stage of sepsis and, if so, whether the degree
of depression could predict eventual outcome. At 6 h post-insult, a stroke volume <0.17 ml prognosticated 3-day
mortality with positive and negative predictive values of 93 and 80%, respectively. Subsequent fluid loading studies
demonstrated intrinsic myocardial depression with poor-prognosis animals tolerating less fluid than either
good-prognosis or sham-operated animals. Cardiac gene expression analysis at 6 h detected 527 transcripts
significantly up- or down-regulated by the septic process, including genes related to inflammatory and cell cycle
pathways. Predicted mortality was associated with significant differences in transcripts of genes expressing
proteins related to the TLR2/MyD88 (Toll-like receptor 2/myeloid differentiation factor 88) and JAK/STAT (Janus
kinase/signal transducer and activator of transcription) inflammatory pathways, β -adrenergic signalling and
intracellular calcium cycling. Our findings highlight the presence of myocardial depression in early sepsis and its
prognostic significance. Transcriptomic analysis in heart tissue identified changes in signalling pathways that
correlated with clinical dysfunction. These pathways merit further study to both better understand and potentially
modify the disease process.
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INTRODUCTION
Sepsis, the systemic inflammatory response syndrome to infec-
tion, is the leading cause of death in the critically ill. This occurs
primarily through the development of multiple organ failure [1],
in which cardiac dysfunction is a well-recognized manifestation
[2,3]. Identified mechanisms for myocardial depression include
Abbreviations: ARDB2 adrenergic receptor β2; ATP2A3, ubiquitous calcium-transporting ATPase; CDKN1A, cyclin-dependent kinase inhibitor 1A; CI, confidence interval; COX2,
cyclo-oxygenase 2; EM, electron microscopy; H&E, haematoxylin and eosin; HMBS, hydroxymethylbilane synthase; HR, heart rate; IL, interleukin; i.p., intraperitoneal; i.v., intravenous;
JAK, Janus kinase; LBP, lipopolysaccharide-binding protein; LV, left ventricular; MyD88, myeloid differentiation factor 88; PDE10A, phosphodiesterase 10A; PKA, protein kinase A;
PLA2G4A, phospholipase A2 group IVA; PP1, protein phosphatase 1; PPP1CB, protein phosphatase 1 catalytic subunit β -isoform; PRKACA, protein kinase cAMP-dependent catalytic α;
PRKAG2, protein kinase AMP-activated γ2; PTGS2, prostaglandin-endoperoxidase synthase 2, ROC, receiver operator characteristic; SERCA, sarcoplasmic/endoplasmic reticulum
Ca2 + -ATPase; SR, sarcoplasmic reticulum; STAT, signal transducer and activator of transcription; TLR, Toll-like receptor.
1 A member of the scientific advisory board of SIRS-Lab GmbH, Jena, Germany, where the microarray experiments were performed.
Correspondence: Professor Mervyn Singer (email m.singer@ucl.ac.uk).
alterations in adrenergic signalling, intracellular calcium cycling,
impaired electromechanical coupling andmitochondrial dysfunc-
tion [4]. The hierarchy of these mechanisms, however, remains
uncertain and individual variations in severity inadequately ex-
plained.
A clinically relevant sepsis model achieving a 50% mortal-
ity rate raises the important but hitherto unaddressed question
www.clinsci.org 391
Cl
in
ic
al
 S
ci
en
ce
   
  	w
w
w
.c
lin
sc
i.o
rg
A. Rudiger and others
as to why some animals survive while the remainder die des-
pite similar, if not, identical characteristics in terms of genotype,
gender, age, weight and environment, and the septic insult re-
ceived. Though these factors differ considerably in humans with
sepsis, resulting in variable degrees and combinations of mul-
tiple organ dysfunction, a wide selection of inflammatory [5],
hormonal [6,7], circulatory [8], bioenergetic [9] and organ dys-
function biomarkers [7,10] can prognosticate as early as the first
few days of intensive care admission. Notably, survivors and non-
survivors are often clinically indistinguishable at this early time
point. This implies that mortality may be determined to a large
extent by a pattern of molecular genetic and functional responses
that differentiate survivors from non-survivors at an early stage.
Although the degree of myocardial depression has been
reported in several clinical studies to be an indicator of poor
outcome [11,12], others suggest this may have a protective
role [13]. This disparity may relate to timing of the study
relative to the duration of critical illness. However, the role
and prognostic significance of early myocardial dysfunction
has received relatively scant attention. We hypothesized that
early cardiac performance could predict eventual outcome, and
performed transcriptomic analysis to probe putative pathways
that could reconcile the physiological and molecular mechanisms
of sepsis-induced cardiac dysfunction.
MATERIALS AND METHODS
Animal model
All experiments were performed according to local ethics com-
mittee (University College London) and Home Office (U.K.)
guidelines under the 1986 Scientific Procedures Act. Under 2%
isoflurane anaesthesia, maleWistar rats (Charles River) had PVC
tubes (inner diameter, 0.58 mm; outer diameter, 0.96 mm) inser-
ted into the right jugular vein and left carotid artery, and tunnelled
subcutaneously to emerge at the nape of the neck. These lines
were subsequently mounted on to a swivel-tether system allowing
the rat, on recovery from anaesthesia, to have unimpeded move-
ment in its cage and free access to food and water. After 24 h,
sepsis was induced by i.p. (intraperitoneal) injection of faecal
slurry (1.8 ml of a 40% preparation obtained from the bowel con-
tent of a rat from the same batch). Fluid resuscitation, consisting
of a 1:1 solution of 6% hetastarch (Elohaes®; Fresenius-Kabi)
and 5% glucose, was commenced 2 h later through the central
venous line. Glucose supplementation prevented hypoglycaemia
in the animals with sepsis due to decreased appetite and intake.
The infusion rate was maintained at 10 ml/kg of body weight per
h between 2 h and 24 h, halving thereafter at 24 h intervals. An-
imals received additional 25 ml/kg of body weight boluses of 6%
hetastarch at 6 h and 10 ml/kg of body weight at 24 h to optimize
fluid resuscitation (results from pilot studies). Sham animals of
similar age, gender and weight underwent identical instrumenta-
tion and fluid administration, but did not receive the i.p. injection
of faecal slurry. At 6, 24, 48 and 72 h post-sepsis induction, and
in sham-operated controls, clinical scoring was performed. This
included an assessment of appearance, alertness and movement,
as previously described [14].
Echocardiography
Echocardiography studies were carried out using a 14 MHz
linear-array transducer connected to a digital ultrasound system
(Vivid 7; GE Healthcare). Images were acquired in left paras-
ternal long and short axis views at the papillary muscle level.
Radius (r) and length (l) of the left ventricle were measured at
end-diastole byM-mode and two-dimensional mode respectively.
LV (left ventricular) end-diastolic volumes were calculated using
a prolate spheroid formula (4/3·π ·r2·l). Stroke volume was meas-
ured in the ascending aorta (radius 1.3 mm) from the velocity–
time integral using pulsed-wave Doppler. The vessel diameter at
this level remains stable despite intravascular volume variations
[15].
Study 1: long-term outcome study
A total of 20 rats with sepsis and eight sham-operated rats (body
weight, 334+− 4.5 g) were monitored for 72 h, and time of death
was recorded. At baseline, 3, 6, 24, 48 and 72 h, spontaneously
breathing animals were removed from their cage, anaesthetized
with isoflurane and placed in a supine position on a warming mat
for echocardiography. The concentration of isoflurane was kept
between 1.0 and 1.5%, so that the animals tolerated the study but
could react to a leg pinch with a withdrawal response.
Study 2: fluid loading study
In 14 rats with sepsis and six sham rats (bodyweight, 305+− 6.0 g)
i.v. (intravenous) fluid resuscitation was started 2 h after the in-
sult with echocardiography performed at 6 h, as described above.
Following echocardiography, animals received a 2.5 ml bolus (ap-
proximately 8 ml/kg of body weight) of 6% hetastarch intraven-
ously over 2 min, and this was repeated at approximately 5 min
intervals. Echocardiography was performed immediately after
each fluid bolus. Bolus fluid administration was repeated until
death occurred.
Study 3: histology
Two sham animals and 11 animals with sepsis were prepared as
above. At 6 h post-insult, echocardiography was performed to
distinguish predicted sepsis survivors from non-survivors. An-
imals were killed at 24 h. Cardiac samples for histology and
EM (electron microscopy) were taken from the LV free wall
at the papillary muscle level and were analysed by blinded
investigators.
Study 4: network-based gene expression analysis
The model was prepared as described above. At 6 h post-insult,
clinical severity was recorded [14] and echocardiography per-
formed to distinguish predicted survivors from non-survivors.
Freshly culled (naı¨ve) and sham-operated animals served as
controls. Hearts (four per group) were promptly removed and
stored in liquid nitrogen. Heart muscle samples (30–50 mg each)
were transferred into 900 μl of lysis solution (RNeasy Mini Kit;
Qiagen) including mercaptoethanol, homogenized in a tissue
lyser at 30 Hz for 4 min at room temperature (Qiagen), then
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Table 1 Differences at 6 h between sham animals, sepsis survivors and sepsis non-survivors
Parameters were recorded at 6 h, before administration of the fluid bolus. Values represent means (+−S.E.M.). Ejection fraction
(EF) was calculated as (stroke volume/end-diastolic volume)×100. *P< 0.05 compared with sepsis survivors; †P< 0.05
compared with sepsis non-survivors; ‡P< 0.05 compared with sham controls. LV, EDV, LV end-diastolic volume; IVC, inferior
vena cava; MAP, mean arterial pressure.
Parameter Sham (n=8) Sepsis survivors (n=5) Sepsis non-survivors (n=15)
Core temperature (◦C) 36.9 (+−0.21) 37.2 (+−0.36) 38.0 (+−0.32)
Respiratory rate (breaths/min) 76 (+−2.8) 78 (+−5.9) 86 (+−3.4)
MAP (mmHg) 129 (+−9.2) 127 (+−5.0) 133 (+−4.1)
HR (beats/min) 411 (+−14) 404 (+−20)† 491 (+−10)‡
LV EDV (ml) 0.52 (+−0.02)* 0.37 (+−0.02) 0.30 (+−0.02)‡
Stroke volume (ml) 0.27 (+−0.02) 0.21 (+−0.03)† 0.12 (+−0.01)‡
Cardiac output (ml/min) 111 (+−3.5) 86 (+−14) 60 (+−4.7)‡
LV EF (%) 53 (+−2.4) 55 (+−7.0) 43 (+−3.5)
IVC diameter (mm) 0.30 (+−0.02) 0.24 (+−0.03) 0.20 (+−0.01)‡
centrifuged and processed further, according to manufacturer’s
instructions. RNA integrity and purity were analysed (Agilent
2100; Agilent), and 300 ng of total RNA was reverse-transcribed
and amplified (Illumina RNA amplification Kit IL1791; Am-
bion). All cRNA samples were quantified with a NanoDrop
spectrophotometer before proceeding to sample hybridization.
A portion (0.75μg of cRNA) of each sample was hybridized to
Sentrix Rat Ref-Seq-12 Beadchips (BD-27-302; Illumina) with
>24000 gene-specific oligonucleotide probes per array, targeting
all known genes and splice variants. The hybridized arrays were
stained with Streptavidin-Cy3 (FluoroLinkTM Cy3TM; Amer-
sham Biosciences), diluted to 1 mg/ml or 1 μg/μl with RNase-
free water, washed, dried and scanned immediately on the Il-
lumina Bead Station. Data were normalized using a variance
stabilizing transformation [16]. For the heatmap, the expression
values of selected genes were Z-score standardized (S.D.= 1,
mean= 0). Data were analysed using Ingenuity Pathway Ana-
lysis (Ingenuity Systems) for functional analyses of the dataset
to identify significant biological functions and diseases connec-
ted with the expression profile. The microarray experiment de-
scription file according to the MIAME checklist is available at
ftp://rudiger2012:Phee5eTh@ftp.sirslab.de/
To confirm changes in mRNA transcript levels, ATP2A3
(ubiquitous calcium transporting ATPase), PRKAG2 (protein
kinase AMP-activated protein kinase γ 2 non-catalytic subunit),
PRKACA (protein kinase cAMP-dependent catalytic α) and
PPP1CB (protein phosphatase 1 catalytic subunit β-isoform)
were quantified by real-time PCR. Results were computed with
specialized software (qBase plus; Biogazelle) and given as the
ratio between the gene of interest and the housekeeping gene
HMBS (hydroxymethylbilane synthase).
Statistics
Results are expressed as means+−S.E.M. or percentages. Con-
tinuous variables were compared with ANOVA. If appropriate,
post-hoc testing was performed using Bonferroni corrections. χ2
testing compared the categorical variables. The quality of stroke
volume as a diagnostic test was described by the area under
the ROC (receiver operator characteristic) curve. Relationships
between gene array and PCR values are described by the square
of the sample correlation coefficient. All testing was two-tailed;
P values <0.05 were considered significant.
RESULTS
Study 1: long-term outcome study
Animals with sepsis developed clinical manifestations of illness
including hunched appearance, piloerection, bloating and leth-
argy, reaching a nadir between 16–48 h. A spectrum of clinical
severity was observed, even between animals from the same lit-
ter, which received the same batch of faecal slurry. Animals with
sepsis showed early signs of sepsis at 6 h after i.p. slurry injection;
their clinical severity score of 2.6+− 0.4 contrasted with 0+− 0 for
sham animals (P< 0.001). However, the clinical severity was
similar between animals predicted to survive or not. Survival
rates at 6, 24, 48 and 72 h were 95, 55, 30 and 25% respectively.
At post-mortem, purulent peritonitis was present with ascites, ad-
hesions and enlarged, fluid-filled bowel loops. Survivors showed
signs of recovery by 72 hwith increased interest in their surround-
ings, improved appetite and appearance. Sham animals became
oedematous yet continued to eat, drink and maintain an interest
in their environment. One sham animal developed a local wound
infection at the tether anchorage site. Two other sham animals
developed right ventricular dilatation, with one dying between
48 and 72 h. All available results are included in the analyses.
Clinical and haemodynamic parameters are displayed in Table 1
and Figure 1. Fluid resuscitation, starting at 2 h and optimized
by a fluid bolus at 6 h, restored preload deficiency in the animals
with sepsis. As a result of the fluid loading, stroke volume and,
consequently, cardiac output increased in all groups.
Stroke volume measured at 6 h was a good discrimin-
ator of outcome, with an area under the ROC curve of
0.83 [95% CI (confidence interval), 0.57–1.1; P= 0.033].
A total of 13 out of the 14 animals with a stroke volume
<0.17 ml died (mortality 93%) compared with one of five
animals with a stroke volume 0.17 ml (mortality 20%, P=
0.006). Hence a 6 h stroke volume <0.17 ml could prognostic-
ate 3-day mortality with high positive and negative predictive
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Figure 1 Temporal changes in haemodynamics
, Sham animals (n= 8); , sepsis survivors (n= 5);, sepsis non-sur-
vivors (n= 15). Values represent means +− S.E.M. Fluid resuscitation
was commenced 2 h after sepsis induction. The infusion rate was main-
tained at 10 ml/kg of body weight per between 2 h and 24 h, and halv-
ing thereafter at 24 h intervals. Animals received additional 25 ml/kg
of body weight fluid boluses at 6 h and 10 ml/kg of body weight at 24 h
to optimize fluid resuscitation. One sham animal died between 48 and
72 h. Significant differences between groups (P< 0.05 by ANOVA) were
found for all four variables at 3 and 6 h (prior to fluid loading). After the
fluid bolus at 6 h, the group difference was only significant for HR.
values of 93 and 80%, respectively. Consequently, this cut-off
value was used in subsequent experiments to distinguish pre-
dicted survivors from non-survivors. Unlike body temperature
and clinical severity, HR (heart rate) measured at 6 h could
also discriminate outcomes [ROC 0.93 (95% CI, 0.81–1.0); P=
0.005], with similar positive (93%) and negative (80%) predict-
ive values. Animals with sepsis with a HR 430/min had a mor-
tality of 93%, whereas those with a HR below this cut-off had a
3-day mortality of only 20% (P= 0.006). Supplementary Table
S1 (at http://www.clinsci.org/cs/124/cs1240391add.htm) shows
the reproducibility of the echocardiography parameters.
Study 2: fluid loading study
Figure 2(A) shows changes in stroke volume with repeated fluid
administration. Predicted non-survivors were fluid-responsive
but failed to reach maximal stroke volumes attained by predicted
survivors or sham-operated animals. Total volume infused before
death was 31+− 7.3 ml in predicted non-survivors, 49+− 6.4 ml in
predicted survivors and 61+− 5.6 ml in sham animals (P< 0.05).
Right ventricular dilatation with increasing septal shift and im-
paired LV filling, suggestive of right heart failure, was seen as a
pre-terminal event (Figure 2B).
Study 3: histology
Only three out of 11 animals with severe sepsis survived until
24 h in this substudy. Tissues from these three animals were com-
pared with tissues from two sham controls. H&E (haematoxylin
and eosin)-stained cardiac tissues showed no signs of nec-
rosis and minimal immune cell infiltration. Oil Red-O staining
failed to demonstrate intracellular lipid accumulation. EM of
hearts from animals with sepsis revealed glycogen accumulations
along clusters of mitochondria and between myofibrils. Although
the contractile apparatus appeared normal, many mitochondria
showed morphological derangements (Figure 3).
Study 4: network-based gene expression analysis
Gene expression profiling of heart tissue from naı¨ve, sham, and
predicted sepsis survivor and sepsis non-survivor subgroups re-
vealed 527 significantly altered gene transcript activities. Figure 4
shows the differences in mean gene expression values between
the groups, displayed as four clusters of co-regulated transcripts.
Cluster 2 represents transcripts of decreased abundance related to
anaesthesia and instrumentation. These differed significantly in
amount between naı¨ve and sham rats; sepsis did not further alter
these transcript levels so this can be interpreted as an ‘injury’
cluster. Here, Ingenuity Pathway Analysis revealed a pronounced
effect on transcript levels reflecting tissue proliferation status
(cell cycle and replication), and a decrease in cAMP signalling
transcripts. Cardiac actin and mitochondrial ribosomal protein
transcripts were also decreased. In addition, down-regulation of
ARDB2 (adrenergic receptor β2) and PRKCA (protein kinase
Cα) may have contributed to the cardiac dysfunction observed
in the animals with sepsis by providing an initial basic trigger
for subsequent sepsis-specific signalling in the adrenergic path-
way. Cluster 4 represents transcripts elevated in sham-operated
compared with naı¨ve animals, but not further affected by sepsis.
Hence, this can be interpreted as a ‘danger’ cluster.
Clusters 1 and 3 represent the changes in transcripts spe-
cific to sepsis. Supplementary Table S2 (at http://www.clinsci.
org/cs/124/cs1240391add.htm) lists all of the increased (65
genes) and decreased (55 genes) transcripts in predicted
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Figure 2 Fluid loading study
(A) Animals with sepsis were classified into predicted non-survivors () [defined by 6 h stroke volume <0.17 ml (n= 8)],
and predicted survivors () [defined by stroke volume 0.17 ml (n= 6)]. Sham animals () served as controls (n= 6).
Values shown illustrate mean stroke volumes at baseline (6 h post-sepsis induction) and post-administration of hetastarch
(25 ml/kg of body weight), maximal stroke volumes reached, intermediate values, pre-terminal values and at death
( = stroke volume 0 ml). Error bars represent S.E.M. Significant differences (P< 0.05 by ANOVA) in stroke volume were
seen between groups at baseline, after 7.5 ml of fluid, and at maximal stroke volume attained. (B) Two-dimensional
echocardiography images acquired in a rat with sepsis at 6 h using parasternal short-axis view at end-diastole. Left-hand
panel: post-administration of 7.5 ml of hetastarch, the left ventricle (broken line) is not compromised, whereas the right
ventricle is hardly visible. Right-hand panel, after administration of 40 ml of hetastarch, the right ventricle is dilated, the
septum (arrow) is flattened and compromises LV filling (broken line).
non-survivors compared with survivors. To study sepsis-specific
events in more detail, subsequent analyses focused on these two
clusters. Compared with the sham group, the main signalling
pathways affected by sepsis were the acute-phase response plus
TLR (Toll-like receptor), IL (interleukin)-6 and IL-10 signalling.
As depicted for the TLR and IL-6 signalling pathways (Fig-
ure 4C), central players of innate immunity [e.g. TLR2, MyD88
(myeloid differentiation factor 88), LBP (lipopolysaccharide-
binding protein) and the JAK/STAT (Janus kinase/signal trans-
ducer and activator of transcription) pathway] responded with
an increase in transcript abundance. Ingenuity Pathway Ana-
lysis of the sepsis-regulated transcripts revealed profound ef-
fects on gene expression activities in animals with sepsis, in-
cluding the functional categories of inflammatory disease, organ
injury and abnormalities, skeletal and muscular disorders, and
cardiovascular disease. Transcript levels of STAT3, REL, c-Myc,
BCL10 and p21, potent regulators of proliferation and apop-
tosis at the transcription level, were increased in response to
sepsis. Key mediators of inflammation such as PLA2G4A (phos-
pholipase A2 group IVA), PTGER4 (prostaglandin E receptor
4) and PTGS2 [prostaglandin-endoperoxidase synthase 2: COX2
(cyclo-oxygenase 2)] were likewise elevated.
Pathways associated with predicted poor outcome included
transcripts encoding for amino-sugar metabolism [PDE10A
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Figure 3 Histological analysis
Light and EM of cardiac tissue in different magnifications taken from a
sham animal (left-hand panels), and 24 h post-sepsis induction from a
predicted non-survivor (right-hand panels). (A and B) Using light micro-
scopy (H&E staining), normal cardiac structures with minimal immune
cell infiltration are shown. (C and D) Structural integrity of the myofibril-
lar apparatus using EM. (E) Normal mitochondria at higher magnification
in a sham animal. (F) A mitochondrion with adjacent glycogen accumu-
lations in a heart taken from an animal with sepsis. The swollen less
electron-dense appearance of the mitochondrion suggests organelle
damage.
(phosphodiesterase 10A), UAP1 (UDP-N-acetylglucosamine
pyrophosphorylase 1) and CYB5R2 (cytochrome b5 reductase
2)] and p53-dependent cell-cycle arrest [CDKN1A (cyclin-
dependent kinase inhibitor 1A), GADD45G (growth-arrest and
DNA-damage-inducible protein 45G) and STAG1 (stromal anti-
gen 1)]. Consistent with the progressive worsening in myocardial
function demonstrated physiologically, significant differences
in transcripts within the β-adrenergic signalling and calcium-
cycling pathways were also linked with an unfavourable out-
come (Figure 5). These included increases in PDE10A, PP1
(protein phosphatase 1) and ITPKC (inositol 1,4,5-trisphosphate
3-kinase C) and decreased SERCA (sarcoplasmic/endoplasmic
reticulum Ca2+ -ATPase). In addition, the PKA (protein kinase
A) transcript was decreased in animals with sepsis compared
with sham animals. The correlations between gene array and
PCR results were good for ATP2A3 and PRKAG2, moder-
ate for PRKACA and absent for PPP1CB (see Supplementary
Figure S1 and Supplementary Table S3 at http://www.clinsci.
org/cs/124/cs1240391add.htm).
DISCUSSION
In the present study, we describe a clinically relevant fluid-
resuscitated long-term (3-day) rodent model of sepsis where
outcome could be determined with high accuracy from haemody-
namic measurements taken early in the illness. This demonstra-
tion of an early difference in phenotype in animals that proceeded
to either recover fully or die occurred notwithstanding similar-
ities in genotype, age, gender and upbringing of these animals,
and receipt of a similar insult. They reflect patient data where,
despite the marked heterogeneity of patient populations, baseline
cardiovascular variables such as HR [8,17], stroke volume [18]
and cardiac output [18,19] could differentiate between survivors
and non-survivors of septic shock. We used echocardiography-
derived measurements of stroke volume for the present study,
which predicted mortality with a high positive and negative pre-
dictive value. Though our focus was on ventricular performance,
we also found a similar predictive ability could be made for HR.
Thismay offer a viable option for future studies if the capability to
measure stroke volume is not available. Our findings suggest that
an increased systemic inflammatory response will compromise
myocardial function through circulating myocardial depressant
factors [20] including NO (nitric oxide) [21], and through altered
gene expression of proteins involved in cardiac contractile and
relaxation pathways (as demonstrated at 6 h in the present study)
and, subsequently (at 12–48 h), in bioenergetic pathways [22].
The lower values of cardiac output in the predicted non-
survivor group did not simply reflect more profound hypo-
volaemia related to a greater degree of capillary leak, as fluid
loading failed to generate either the maximal stroke volumes at-
tained by the sham or sepsis survivor groups, nor did it reduce
HR. Notably, all animals with sepsis at 6 h were normotensive
(Table 1) and had received 40 ml/kg of body weight (equivalent
to 3 litres in humans) between 2 and 6 h. Intrinsic myocardial
depression was, however, confirmed by a progressive decrease in
tolerance to large volume fluid loading in the animals with sepsis;
this occurred to a much greater extent in predicted non-survivors.
Hollenberg et al. [23] reported myocardial depression in mice
with sepsis, despite the co-existence of a high cardiac output.
These findings reflect those made in clinical echocardiographic
studies, someofwhich could also prognosticate as early as the first
day of ICU (intensive care unit) admission [12,24,25]. As seen
in this study, the failing thinner-walled right ventricle copes less
well with excessive fluid loading; this will likely be compounded
in sepsis by co-existing (acute) lung injury, increasing pulmonary
artery pressures and right ventricular afterload. A careful balance
must therefore be reached between an avoidance of excess fluid
that will compromise myocardial function and worsen interstitial
oedema [26], and sufficient fluid administration to rescue the
macrocirculation, improve organ perfusion and enhance survival
[26]. As our data demonstrate, the sicker the animals with sepsis
become, the less fluid loading they are able to tolerate.
396 C© The Authors Journal compilation C© 2013 Biochemical Society
Cardiac dysfunction during early sepsis
Figure 4 Network-based gene expression analysis
(A) Heatmap highlighting significant differences in 527 mean gene expression values between the four clinical groups
(n= 4 per group). These are displayed as four clusters of transcripts with similar gene activity patterns. Associated colours
represent variance-normalized expression values relative to the mean expression of each transcript within this experiment.
Red and blue indicate relative increase or decrease of transcript abundance, respectively. (B) Gene expression values of
one representative transcript for each of the four clusters, illustrating the relative transcript abundance in each cluster.
For cluster 1: Cited4 [CBP (cAMP-response-element-binding protein) interacting transactivator-4], cluster 2: Nrep (neuronal
protein 3.1), cluster 3: SELP (selectin-P) and cluster-4: Mt1a (metallothionein-1a). (C) Signalling pathways most prominently
activated/altered in the sepsis cluster (cluster 3). Both TLR and IL-6 signalling lead to transcriptional activation of central
regulators of proliferation, cell death and immune response. MKK3/MKK6, mitogen-activated-protein-kinase kinase 3/6,
PAI-1, plasminogen activator inhibitor-1, HAS-1, hyaluronan synthase-1; TRH, thyrotropin-releasing hormone, MCL, myeloid
cell leukaemia sequence 1 (BCL2-related), IL4R: IL-4 receptor. The Ingenuity Pathway Analysis Figure is c© 2000–2008
Ingenuity Systems, Inc. All rights reserved.
Histology demonstrated negligible cardiac tissue necrosis,
supporting previous findings in animals with sepsis [15,27,28]
and in non-survivors of human septic shock [29,30]. EM did
display evidence of mitochondrial swelling, suggesting organelle
damage, confirming previous work by ourselves and others in an-
imals [21,22,28,31–33] and patients [34] with sepsis. The finding
of glycogen accumulation in cardiomyocytes from animals with
sepsis, as reported previously [35], has also been identified in
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Figure 5 Myocardial transcriptomics revealing transcript alterations in β-adrenergic signalling and Ca2+ flux pathways
depending on disease severity
Cardiomyocyte contraction depends on intracellular Ca2 + regulated by catecholamines acting on the ARβ2, with sub-
sequent activation of Gs (stimulatory G-proteins) and elevation of cAMP. This activates PKA, phosphorylating PLN (phos-
pholamban), an SR transmembrane protein. Depending on its own phosphorylation state, PLN promotes the active state of
the Ca2 + ATPase SERCA, favouring Ca2 + uptake into the SR. PP1 dephosphorylates PLN, deactivating SERCA. Ca2 + entry
into the cell through L-type calcium channels triggers Ca2 + -mediated Ca2 + release from the SR via RyRs (ryanodine recept-
ors). This dictates the degree of actin–myosin cross-bridge formation and the strength of contraction. Relaxation occurs
when cytosolic Ca2 + is lowered primarily by activity of SERCA, as well as plasmalemmal Ca2 + -ATPases and Na+ /Ca2 +
exchangers. Compared with predicted survivors, predicted non-survivors showed increased (red) cardiac gene transcripts
for PDE10 (phosphodiesterase 10), PP1 and RyR3, whereas SERCA transcript abundance was decreased (blue). The
β2AR (β2-adrenergic receptor) and PKA transcript levels were decreased in hearts from animals with sepsis, but did not
reach statistical significance between predicted survivors and non-survivors. The Ingenuity Pathway Analysis Figure is c©
2000–2008 Ingenuity Systems, Inc. All rights reserved.
hibernating myocardium of pigs following ischaemia [36]. In
summary, structural tissue damage was minor, although changes
were apparent at the subcellular level. These observations sup-
port our hypothesis that myocardial dysfunction is a functional
rather than a structural derangement [4,37].
This descriptive approach to myocardial depression in sepsis
can be systematically studied in the present model by applying
genome-wide analysis of alterations in the myocardial transcrip-
tome. To this end, we employed a structured network knowledge-
based approach that can provide insights into regulation of cell
function and interaction, as demonstrated in healthy volunteers
treated with endotoxin [38]. Although we cannot yet describe
precise mechanisms through which these changes occur, sepsis
clearly elicits significantly different responses compared with
sham operation alone, and that some of these are differentially
expressed and associated with poor outcome.
The genome-wide profiling revealed early up-regulation of
TLR2/MyD88 and JAK/STAT3-dependent signallingwith sepsis.
This supports findings of improved cardiac function, with nor-
mal sarcomere shortening and peak change in intracellular
Ca2+ , in TLR2− /− mice undergoing caecal ligation and punc-
ture compared with their wild-type equivalents [39]. Although
the JAK/STAT3 pathway is generally considered to be cardio-
protective [40], it too can contribute to cardiac dysfunction dur-
ing ischaemia [41]. A study of rats undergoing cecal ligation
and puncture reported attenuated organ failure and improved sur-
vival rates following JAK/STAT3 pathway inhibition, although
the heart was not specifically examined [42].
Importantly, in relation to the physiological changes recorded
in this model, myocardial transcriptomics revealed alterations
in transcript abundance linked to β-adrenergic signalling and
Ca2+ flux that depended on disease severity and prognosis (Fig-
ure 5). Although mindful of the limitations in interpreting tran-
scriptomic data, it is conceivable that such transcript differences
could impact on myocardial function. In our model, the PKA
transcript level was significantly decreased in the animals with
sepsis, whereas PDE10 transcript abundance was elevated. PDE
increases breakdown of cAMP, further reducing PKA activity
[43]. Increased activity of PP1 dephosphorylates phospholam-
ban, reducing Ca2+ uptake into the SR (sarcoplasmic reticulum)
[44]. Down-regulation of SERCA has a similar effect [45]. Up-
regulation of PP1 and down-regulation of PKA also reduce Ca2+
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entry into the cell by inhibiting L-type calcium channels [46].
A diminution in L-type calcium current was reported recently in
ventricular myocytes isolated from pigs with sepsis [47]. High
cytosolic and lowSRCa2+ levels lead to failure of diastolic relax-
ation and impaired systolic contraction, respectively. Both these
aspects are also recognized in septic cardiomyopathy [4,48].
We focused our transcriptomic analyses on heart tissue as
our prognostic tool was based on an assessment of myocardial
dysfunction. Analyses of liver tissue taken concurrently show
significant differences in other signalling pathways [49]. It is thus
reasonable to speculate that each organ has its own transcriptomic
response to infection. A better understanding of each organ’s
response, and interactions between organs, may provide useful
clues to developing novel therapies.
In summary, our findings emphasize both the presence and
prognostic significance of cardiac dysfunction with intrinsic
myocardial depression during early sepsis, at a time when over-
all clinical severity was not marked. The poor-prognosis animals
had reduced tolerance to i.v. fluid loading, highlighting the im-
portance of adequate but not excessive fluid administration in
clinical management. Our study implies that outcome is already
determined at an early stage in sepsis. Greater or lesser degrees
of gene up- or down-regulation, with the likely addition of post-
transcriptional modifications that were notmeasured in this study,
will distinguish eventual survivors and non-survivors. If con-
firmed, this has major consequences for patient management as
a proportion are clearly not benefiting from current approaches;
new paradigmswould need to be introduced to improve outcomes
in such patients.
CLINICAL PERSPECTIVES
 Myocardial function is depressed in sepsis and is an important
prognosticator in patients.
 Using a long-term fluid-resuscitated rat model of faecal peri-
tonitis, we demonstrate that significant differences in stroke
volume and HR measured 6 h post-insult could predict 3-day
mortality with positive and negative predictive values of 93
and 80% respectively. In separate studies, cardiac gene ex-
pression analysis at 6 h detected 527 transcripts significantly
up- or down-regulated by the septic process, including genes
related to inflammatory and cell cycle pathways. The degree
of change in these signalling pathways correlated with clinical
dysfunction.
 These findings suggest a crucial role for early cardiovascular
performance in determining subsequent outcome, with clear
therapeutic implications.
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Early functional and transcriptomic changes in
the myocardium predict outcome in a long-term
rat model of sepsis
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Table S1 Reproducibility of echocardiography parameters
Intra-observer variability is the variability between two analyses of the same study. Inter-observer variability is the variability
between two observers analysing the same study. Inter-study variability is the variability between data acquired at two
time-points within 24 h, recorded and analysed by one investigator. Variability is calculated as the difference between two
observations divided by the mean of the two observations and expressed as percentage. LV EDV, LV end-diastolic volume; LV
EF, LV ejection fraction; IVC inferior vena cava.
Naı¨ve animals (n=10) Animals with sepsis at 6 h (n=10)
Intra-observer Inter-observer Inter-study Intra-observer Inter-observer
Paramter variability (%) variability (%) variability (%) variability (%) variability (%)
HR (beats/min) 0.39 (0.14) 0.63 (0.10) 6.7 (1.4) 0.70 (0.13) 0.85 (0.19)
LV EDV (ml) 4.5 (1.2) 7.7 (1.7) 8.8 (2.3) 8.1 (1.5) 8.9 (2.0)
Stroke volume (ml) 2.1 (0.35) 3.6 (0.7) 6.1 (1.7) 7.8 (1.6) 6.4 (1.1)
Cardiac output (ml/min) 1.9 (0.35) 3.9 (0.79) 3.9 (0.78) 7.5 (1.5) 5.9 (1.1)
LV EF (%) 5.1 (1.2) 5.8 (1.2) 8.2 (1.9) 11 (2.3) 14 (2.8)
IVC diameter (mm) 5.4 (1.1) 7.6 (2.4) 13 (3.7) 6.8 (2.1) 3.5 (1.3)
1 A member of the scientific advisory board of SIRS-Lab GmbH, Jena, Germany, where the microarray experiments were performed.
Correspondence: Professor Mervyn Singer (email m.singer@ucl.ac.uk).
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Table S2 Genes significantly up-regulated or down-regulated in predicted sepsis non-survivors compared with survivors
(clusters 1 and 3)
Gene
Molecule regulation Description Location Type
ABCG3 (includes EG:27405) Down ABC (ATP-binding cassette), sub-family G
(WHITE), member 3
Plasma membrane Transporter
AFF4 Up AF4/FMR2 family, member 4 Nucleus Transcription regulator
ALMS1 Down Alstrom syndrome 1 Cytoplasm Other
APLN Down apelin, AGTRL1 ligand Extracellular space Other
APOBEC3F Up Apo B (apolipoprotein B) mRNA editing
enzyme, catalytic polypeptide-like 3F
Unknown Enzyme
ARHGEF9 Down Cdc42 GEF (guanine-nucleotide-exchange
factor) 9
Cytoplasm Other
ARL5A Up Arf (ADP-ribosylation factor)-like 5A Unknown Enzyme
ATP2A3 Down ATPase, Ca2 + transporting, ubiquitous Cytoplasm Transporter
BCL10 Up B-cell CLL/lymphoma 10 Cytoplasm Transcription regulator
BCR Up Breakpoint cluster region Cytoplasm Kinase
BTG2 Up BTG family, member 2 Nucleus Transcription regulator
C11ORF54 Down Chromosome 11 open reading frame 54 Nucleus Other
C14ORF172 Up Chromosome 14 open reading frame 172 Unknown Enzyme
C4ORF14 Up Chromosome 4 open reading frame 14 Cytoplasm Other
CC2D2A Down Coiled-coil and C2 domain containing 2A Unknown Other
CD55 Up CD55 molecule, decay accelerating factor for
complement (Cromer blood group)
Plasma membrane Other
CDC42SE1 Up CDC42 small effector 1 Plasma membrane Other
CDK5 Down Cyclin-dependent kinase 5 Nucleus Kinase
CDKN1A Up cyclin-dependent kinase inhibitor 1A (p21,
Cip1)
Nucleus Kinase
CES1 (includes EG:1066) Up Carboxylesterase 1 (monocyte/macrophage
serine esterase 1)
Cytoplasm Enzyme
CH25H Up Cholesterol 25-hydroxylase Cytoplasm Enzyme
CLCN3 Up Chloride channel 3 Plasma membrane Ion channel
CYB5R2 Down Cytochrome b5 reductase 2 Unknown Enzyme
CYP2U1 Down Cytochrome P-450, family 2, subfamily U,
polypeptide 1
Unknown Enzyme
DDB2 Down Damage-specific DNA binding protein 2,
48kDa
Nucleus Other
DDIT4L Down DNA-damage-inducible transcript 4-like Unknown Other
DEPDC7 Up DEP domain containing 7 Unknown Other
DTWD1 Down DTW domain containing 1 Unknown Other
DUSP11 Up Dual specificity phosphatase 11 (RNA/RNP
complex 1-interacting)
Nucleus Phosphatase
EGFLAM Down EGF-like, fibronectin type III and laminin G
domains
Unknown Other
ENPP1 Down Ectonucleotide
pyrophosphatase/phosphodiesterase 1
Plasma membrane Enzyme
EVL Down Enah/Vasp-like Cytoplasm Other
FAM81A Down Family with sequence similarity 81, member A Unknown Other
FHL1 Up four and a half LIM domains 1 Cytoplasm Other
FLJ21865 Down Endo-β -N-acetylglucosaminidase Unknown Enzyme
FLNC Up Filamin C, gamma (actin binding protein 280) Cytoplasm Other
FOXK2 Up Forkhead box K2 Nucleus Transcription regulator
GADD45G Up Growth arrest and DNA-damage-inducible,
gamma
Nucleus Other
GALM Down Galactose mutarotase (aldose 1-epimerase) Cytoplasm Enzyme
GALNACT-2 Up Chondroitin sulfate GalNAcT-2 Cytoplasm Enzyme
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Table S2 Continued
Gene
Molecule regulation Description Location Type
GCGR Down Glucagon receptor Plasma membrane G-protein coupled receptor
GEM Up GTP-binding protein overexpressed in skeletal
muscle
Plasma membrane Enzyme
GRN Down Granulin Extracellular space Growth factor
HAS1 Up Hyaluronan synthase 1 Plasma membrane Enzyme
HIP1 Down Huntingtin interacting protein 1 Cytoplasm Other
HRSP12 Down Heat-responsive protein 12 Cytoplasm Other
ITPKC Up Inositol 1,4,5-trisphosphate 3-kinase C Unknown Kinase
JAG2 Down jagged 2 Extracellular space Growth factor
KCNK2 Down Potassium channel, subfamily K, member 2 Plasma membrane Ion channel
KRCC1 Up Lysine-rich coiled-coil 1 Unknown Other
LOC499828 Up Similar to copine VIII isoform 1 Unknown Other
MAGED2 Down melanoma antigen family D, 2 Plasma membrane Other
MAP2K6 Down Mitogen-activated protein kinase kinase 6 Cytoplasm Kinase
MATN2 Down Matrilin 2 Extracellular space Other
MDM1 Down Mdm4, transformed 3T3 cell double minute
1, p53 binding protein (mouse)
Unknown Other
METTL6 Up Methyltransferase like 6 Unknown Enzyme
MGC70857 Down Similar to RIKEN cDNA C030006K11 gene Unknown Other
MLL5 Down Myeloid/lymphoid or mixed-lineage leukemia
5 (trithorax homologue, Drosophila)
Nucleus Other
MMD Down Monocyte to macrophage
differentiation-associated
Plasma membrane Other
MRTO4 Up mRNA turnover 4 homologue (S. cerevisiae) Cytoplasm Other
MYC Up v-myc myelocytomatosis viral oncogene
homologue (avian)
Nucleus Transcription regulator
MYOT Up Myotilin Cytoplasm Other
NCF4 Up Neutrophil cytosolic factor 4, 40 kDa Cytoplasm Enzyme
NR0B2 Down Nuclear receptor subfamily 0, group B,
member 2
Nucleus Ligand-dependent nuclear
receptor
NRM Down Nurim (nuclear envelope membrane protein) Nucleus Other
NSUN5 Up NOL1/NOP2/Sun domain family, member 5 Unknown Other
OLR1117 PREDICTED Up Olfactory receptor 1117 (predicted) Plasma membrane G-protein coupled receptor
OPN4 Up Opsin 4 (melanopsin) Plasma membrane G-protein coupled receptor
OR51E2 Down Olfactory receptor, family 51, subfamily E,
member 2
Plasma membrane G-protein coupled receptor
PDE10A Up Phosphodiesterase 10A Cytoplasm Enzyme
PIK3IP1 Down Phosphoinositide-3-kinase interacting protein
1
Unknown Other
PPP1CB Up Protein phosphatase 1, catalytic subunit, β
isoform
Cytoplasm Phosphatase
PPP1R15A (includes EG:23645) Up Protein phosphatase 1, regulatory (inhibitor)
subunit 15A
Cytoplasm Other
PUS7 Up Pseudouridylate synthase 7 homologue (S.
cerevisiae)
Unknown Other
PVR Up poliovirus receptor Plasma membrane G-protein coupled receptor
RAB40B Down RAB40B, member RAS oncogene family Plasma membrane Enzyme
RBM13 Up RNA binding motif protein 13 Nucleus Other
REL Up v-rel reticuloendotheliosis viral oncogene
homologue (avian)
Nucleus Transcription regulator
RGD1559728 PREDICTED Up RGD1559728 (predicted) Unknown Other
RGD1559957 PREDICTED Up RGD1559957 (predicted) Unknown Other
RGD1561949 PREDICTED Up Similar to spermidine synthase (predicted) Unknown Other
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Table S2 Continued
Gene
Molecule regulation Description Location Type
RGD1562388 PREDICTED Down Similar to ORF2 consensus sequence encoding
endonuclease and reverse transcriptase
minus RNaseH (predicted)
Unknown Other
RGD1564483 PREDICTED Up Similar to ARP2/3 complex 16 kDa subunit
(p16-ARC) (predicted)
Unknown Other
RGD1564567 PREDICTED Up Similar to CG14998-PC, isoform C (predicted) Unknown Other
RGS2 Up Regulator of G-protein signalling 2, 24kDa Nucleus Other
RND1 Up Rho family GTPase 1 Cytoplasm Enzyme
RYR3 Up Ryanodine receptor 3 Plasma membrane Ion channel
SCRIB Down Scribbled homologue (Drosophila) Cytoplasm Other
SCRN1 Down Secernin 1 Cytoplasm Other
SELP Up Selectin P (granule membrane protein 140 kDa,
antigen CD62)
Plasma membrane Other
SH3BGRL2 Up SH3 domain binding glutamic acid-rich protein
like 2
Plasma membrane Other
SIAH2 Up Seven in absentia homologue 2 (Drosophila) Nucleus Transcription regulator
SLC20A1 Up Solute carrier family 20 (phosphate transporter),
member 1
Plasma membrane Transporter
SLC37A2 Down Solute carrier family 37 (glycerol-3-phosphate
transporter), member 2
Unknown Transporter
SLC37A4 Down Solute carrier family 37 (glucose-6-phosphate
transporter), member 4
Cytoplasm Transporter
SNRPA1 Up Small nuclear ribonucleoprotein polypeptide A’ Nucleus Other
SOX4 Down SRY (sex-determining region Y)-box 4 Nucleus Transcription regulator
SP3 Up Sp3 transcription factor Nucleus Transcription regulator
STAB1 Down Stabilin 1 Plasma membrane Transporter
STAG1 Up Stromal antigen 1 Nucleus Other
STAT3 Up Signal transducer and activator of transcription 3
(acute-phase response factor)
Nucleus Transcription regulator
TCF3 Down Transcription factor 3 (E2A immunoglobulin
enhancer binding factors E12/E47)
Nucleus Transcription regulator
TGS1 Up Trimethylguanosine synthase homologue (S.
cerevisiae)
Nucleus Transcription regulator
TMEM53 Down trans-Membrane protein 53 Unknown Other
TP53I11 Down Tumour protein p53 inducible protein 11 Unknown Other
TREM2 Down Triggering receptor expressed on myeloid cells 2 Plasma membrane trans-membrane receptor
TRH Up Thyrotropin-releasing hormone Extracellular space Other
TRIB1 Up Tribbles homologue 1 (Drosophila) Cytoplasm Kinase
TUBB6 Up Tubulin, β 6 Cytoplasm Other
UAP1 Up UDP-N-acetylglucosamine pyrophosphorylase 1 Nucleus Enzyme
UNC5C Down unc-5 homologue C (C. elegans) Plasma membrane trans-membrane receptor
UROD Down Uroporphyrinogen decarboxylase Cytoplasm Enzyme
USPL1 Up Ubiquitin specific peptidase like 1 Unknown Other
VPS45 Down Vacuolar protein sorting 45 homologue (S.
cerevisiae)
Cytoplasm Transporter
WDR60 Down WD repeat domain 60 Unknown Other
WDR67 Down WD repeat domain 67 Unknown Other
XIRP1 Up Xin actin-binding repeat containing 1 Plasma membrane Other
ZFP472 Down Zinc finger protein 472 Unknown Other
ZFP61 Down Zinc finger protein 61 Unknown Peptidase
ZMYND19 Up Zinc finger, MYND-type containing 19 Plasma membrane Other
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Table S3 Correlation between gene array and PCR values
Correlations between gene array and real-time PCR values for ATP2A3,
PRKAG2, PRKACA and PPP1CB.
Pearson’s Square of the
correlation correlation
Gene coefficient (r) coefficient (R2) P value
ATP2A3 (n= 16) 0.802 0.643 <0.001
PRKAG2 (n= 16) 0.753 0.567 0.001
PRKACA (n= 14) 0.625 0.391 0.017
PPP1CB (n= 16) 0.201 0.040 0.455
Figure S1 Correlation between gene array and real-time PCR values
(A) ATP2A3, (B) PRKAG2, (C) PRKACA and (D) PPP1CB. PCR results are given as the ratio between the gene of interest
and the housekeeping gene HMBS.
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